Provided by Tiger Fintech (Singapore) Pte. Ltd.

GlaxoSmithKline PLC

39.30
+0.49001.26%
Post-market: 39.460.1575+0.40%19:59 EST
Volume:5.51M
Turnover:215.73M
Market Cap:80.14B
PE:25.23
High:39.42
Open:38.61
Low:38.60
Close:38.81
Loading ...
Jul 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 30, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 22, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 17, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 04, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 26, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 04, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Apr 14, 2020

Report of foreign issuer

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 14, 2020

Report of foreign issuer

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 14, 2020

Report of foreign issuer

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 14, 2020

Report of foreign issuer

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 09, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 06, 2020

Report of foreign issuer

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 01, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 01, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 30, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]